Comparative study of a moisturizer and topical tarcrolimus for treating atopic dermatitis
Not Applicable
Completed
- Conditions
- Diseases of the skin and subcutaneous tissue
- Registration Number
- KCT0007962
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Eligible patients are 20-70 years old with a diagnosis of clinically stable AD. Diagnosis of AD is performed by a board-certified dermatologist using Hanifin and Rajka’s criteria. Patients are required to have Eczema Area and Severity Index (EASI) scores of = 7 (mild) or 7-21 (moderate).
Exclusion Criteria
Active states of other dermatitis or eczematous conditions, skin infection requiring oral or topical antimicrobial therapy, or previous treatment with oral or topical corticosteroids or immunosuppressants within the past four weeks.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Investigator’s Global Assessment ;modified Eczema Area and Severity Index (mEASI)
- Secondary Outcome Measures
Name Time Method skin biophysical parameters (hydration, transepidermal water loss, erythema index, melanin index)